Norway Life Science 2024: How can Norway get more out of health data?

Norway's largest and most important conference for health and life science, Norway Life Science 2024, will take place 13 – 14 February.

NB: The conference is now full.

NMBU-rector Siri Fjellheim and NMBU-scientists Olav Reksen (Vet), Gareth Difford (Biovit) and Hans Jørgen Overgaard (Realtek) are among the speakers at the conference.

The main theme of the conference is health data, and the aim is to help increase Norway's competitiveness in access to and use of such data – both for human and animal health.

Compared to our European neighbouring countries, Norway gets less return from the large investments in health research in the form of patents, new companies, and export revenues from the health industry.

Better access to health data for research and innovation, within clear ethical and privacy boundaries, will help strengthen Norwegian research environments, develop better treatments for patients, and create new jobs and export revenues.

At the conference, we gather the entire value chain for health and life science. Andrew Morris, Director of Health Data Research UK, shares experiences from the UK, and key actors from Finland, Denmark and Sweden will talk about measures and initiatives to make health data available for developing new knowledge and treatments.

You also get to hear from the country's leading research environments, the central leaders in the health sector, world-leading pharmaceutical companies, startup environments, investors, and decision-makers.

The conference is organised by University of Oslo, together with Oslo Science City, Oslo University Hospital, NMBU – Norwegian University of Life Sciences, SINTEF, Association of the Pharmaceutical Industry in Norway, Oslo Cancer Cluster and The Life Science Cluster.

Facebook-event